Companies /Healthcare

Humana Inc

NYSE: HUM Healthcare Plans
$380.10
▼ $5.69 (−1.47%) today
Markets closed · 6:11pm ET

24/7 Wall St. View

HUM at a Glance

Valuation
Market cap
$46.3B
P/E ratio
37.6
Dividend yield
0.80%
Profitability
Revenue (TTM)
$154.2B
Profit margin
0.8%
EPS (TTM)
$10.25
Price
52-week range
$162 – $463
Street target
$504.17
Earnings
Next report
Feb 9, 2027
Q3 2026 EPS
$-0.70
vs. $-1.00 est.
+30.3%

Headquartered in Louisville, KY Fiscal year ends December NYSE: HUM humana.com

About Humana

Humana Inc. is a U.S. healthcare company with two reportable segments: Insurance and CenterWell.

The Insurance segment offers insurance products to Medicare and state-based contract (Medicaid) beneficiaries, individuals and employers. As of September 30, 2026, it served about 18 million medical members. Its products include:
- individual and group Medicare Advantage, with about 6.46 million individual MA members, including about 958,300 D-SNP members;
- stand-alone Medicare Part D prescription drug plans, with about 4.03 million members;
- Medicare Supplement;
- Medicaid and integrated dual-eligible programs across a 13-state footprint;
- TRICARE East Region military services;
- dental, vision and other specialty benefits.

The segment also includes Humana's pharmacy benefit manager (PBM) business. Insurance revenues are heavily concentrated in Medicare and depend on CMS benchmark funding, risk-adjustment models and Star Ratings quality bonuses.

The CenterWell segment provides health care services to Humana members and a growing payor-agnostic client base. Its three businesses are:
- CenterWell Pharmacy, including mail-order and CenterWell Specialty Pharmacy, with expanding Direct to Consumer and Direct to Employer volumes;
- CenterWell Senior Primary Care, serving about 638,000 patients across 399 centers and independent physician associations;
- CenterWell Home Solutions, including home health.

Humana has expanded CenterWell through acquisitions such as The Villages Health and MaxHealth. In October 2026 it closed a non-consolidating primary care joint venture with HPS Investment Partners, a BlackRock subsidiary, replacing prior JVs with Welsh, Carson, Anderson & Stowe. It is also divesting its minority interest in Gentiva. Updated

Latest Activity

Anthropic IPO, Fed Shock Talk and Health Insurer Sell-Off

  • Waller's talk of a 50bp December hike, a 19-month-high dollar and falling oil have Tim Seymour flagging an unpriced growth scare
  • Anthropic priced at $83, roughly a $1.5 trillion valuation and the largest IPO ever; Gil Luria expects a $100 day-one pop
  • Luria: the whole AI capex cycle rides on the deal working, with Amazon, Google and Broadcom most exposed
  • Proposed CRUSH health rules drove double-digit drops in UnitedHealth, Humana and Centene; Mike Coe would sell premium to get long UNH

Rate hike risk and collapsing commodities matter more right now than Nvidia's quarter. Anthropic's IPO debut becomes a referendum on AI spending itself, with Luria urging patience on entry given no comparables. Palo Alto beat and raised with 66% next-gen security ARR growth, yet Seymour still calls cybersecurity valuations too rich to chase.

CLOVClover Health
Regular session
$4.30
-8.60%off the open $4.71

An 8.6% slide to $4.31 came alongside declines across managed care: Humana fell 8.46%, Elevance 6.27% and CVS 3.19% in the same session. These names are moving together today.

Related stockstoday
  • HUMHumanaCompetitor-8.5%
    Dec 31, 2025 · SEC 10-K · Nov 18, 12:00 PM ET · Alpha Vantage quote
  • ELVElevance HealthCompetitor-6.3%
    Dec 31, 2025 · SEC 10-K · Nov 18, 2:20 PM ET · Alpha Vantage quote
  • CVSCVS HealthCompetitor-3.2%
    Feb 27, 8:08 AM ET · SEC 10-K · Nov 18, 2:20 PM ET · Alpha Vantage quote

2 more related stocks · 4 have no US listing

HUMHumana
Regular session
$404.02
-8.46%off the open $441.37

Humana has given up 8.46% from its $441.37 open. A move this size intraday is worth watching into the close.

Related stockstoday

Moves: Nov 18, 12:00 PM ET · Alpha Vantage quote

Biggest movers · On the open
  • SNAPSnap$5.34+4.8%
  • COHRCoherent$213+4.7%
  • FUBOfuboTV$7.65+3.5%
  • SPCXSpaceX$141.68+3.1%
  • GPROGoPro$0.63+3.0%
  • UNHUnitedHealth Group$395.5-4.0%
  • HUMHumana$443.02-3.9%
  • MFGMizuho Financial Group$9.87-3.8%
  • CRMSalesforce$207.01-3.7%
  • ASANAsana$9.55-3.5%

Managed care is carrying the damage at the open, with UnitedHealth down 4% and Humana close behind. Snap leads the upside, leaving roughly eight points between the day's best and worst movers.

Biggest movers · At the close
  • BILLBill Holdings$57.31+5.2%
  • ELVElevance Health$446.11+3.8%
  • HUMHumana$462.49+2.7%
  • DUOLDuolingo$169.56+2.6%
  • HCAHCA Healthcare$511.55+2.5%
  • IQiQIYI$0.69-17.3%
  • NVTSNavitas Semiconductor$7.9-11.8%
  • IRENIREN$16.35-10.0%
  • AAOIApplied Optoelectronics$44.95-9.9%
  • TEMTempus AI$64.65-9.7%

Sellers controlled the close, with iQIYI down 17.27% on the day it filed third quarter results and no gainer topping a fraction of that. Healthcare took the top three slots after Bill Holdings.

52-week highs
43stocks hit new 52-week highs this week
  • MSIMotorola Solutions$530.42+7.7%
  • IBNICICI Bank$34.51+7.2%
  • EWEdwards Lifesciences$107.19+6.4%
  • TEVATeva$44.54+5.8%
  • FASTFastenal Company$55.55+4.4%
  • CAHCardinal Health$281.14+4.4%
  • MRNAModerna$223.37+4.1%
  • HUMHumana$450.47+3.9%
  • ICEIntercontinental Exchange$178.49+3.3%
  • KOCoca-Cola Company$99.26+3.3%

43 stocks notched fresh 52-week highs this week, with leadership spread across Motorola Solutions, ICICI Bank, Edwards Lifesciences, Coca-Cola, Humana and Fastenal. Motorola Solutions leads at $530.42, 7.7% past its prior peak.

Nvidia Fallout, AI Financing Risk and Apple’s Safe-Haven Surge

  • Jensen Huang's exit leaves Nvidia down nearly a third from its $6 trillion peak, with the vendor-financing web in question
  • DA Davidson's Gil Lauria keeps a Buy but cuts his target to $200, preferring AMD, Broadcom and Micron near term
  • 10-year yields above 5.1% make neocloud financing costlier; NScale's S1 shows $5.5B of debt
  • Apple at 39x forward earnings framed as a Costco- or Walmart-style safe haven

Capital is rotating within the AI trade, moving from the Nvidia complex toward AMD and Micron, while Apple gets priced like a staple on 90% iPhone loyalty and almost no AI capex. The pressure point is funding costs, with debt-heavy neocloud borrowers the first to feel a higher 10-year yield.

Sold HUMANA INC$2.4M5,495 shares @ $433.851

Humana's Joseph C. Ventura parted with about a quarter of his stake in a single $2.38 million sale, with no 10b5-1 plan disclosed to explain the timing. It lands while the company is flagging 2027 market exits and warning about flat Medicare Advantage rates, so insider conviction is worth tracking here.

HUMHumana
52-week high
$437.97
+1.03%vs prior 52-week high · Oct 12, 2026

The managed-care name is back at the top of its range.

Related stockstoday
CLOVClover Health
After-hours
$4.82
+9.05%off the open $4.42

The 9.05% run came the same day Humana, a competitor, posted Q3 2026 results. Managed care names moved together into the close.

Before the movelast 24 hours
  1. Earnings release
    Related company: HUM, competitor

    Humana Q3 2026 earnings release

Related stockstoday

Moves: Nov 6, 4:20 PM ET · Alpha Vantage quote

3 more related stocks · 4 have no US listing

HUM Coverage

Frequently Asked Questions

What does Humana do?

Humana Inc. is a U.S. healthcare company with two reportable segments: Insurance and CenterWell. The Insurance segment offers insurance products to Medicare and state-based contract (Medicaid) beneficiaries, individuals and employers.

What is the HUM stock price target?

The Wall Street consensus 12-month price target for HUM is $504.17. HUM price prediction →